文献速递贫血与红细胞疾病白血病造血干细胞移植与细胞治疗

32例JAGN1缺陷患者的扩展临床表型与治疗方式:ESID与EBMT IEWP多中心研究

Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients: a multicenter study by ESID and EBMT IEWP.
PubMed 文献 · Blood Adv · 2025-01-01

这项回顾性多中心研究收集了32例JAGN1缺陷患者数据,描述疾病表型、进行表型-基因型分析并评估治疗方式。所有患者均出现感染并发症,12例表现为身材矮小和面部特征,4例出现神经发育迟缓。6例因难治性中性粒细胞减少和严重感染接受异基因造血干细胞移植,1例因骨髓增生异常综合征和继发性急性髓系白血病接受移植,2例因自体重建需二次移植,1例未移植患者死于全结肠炎和败血症。

要点

  • 所有32例JAGN1缺陷患者均出现感染并发症,12例有身材矮小和面部特征,4例有神经发育迟缓。
  • 变异c.3G>A p.Met1见于9例患者,除1例身材矮小外从未与髓外症状相关。
  • 6例因难治性中性粒细胞减少和严重感染接受异基因造血干细胞移植,1例因MDS和继发性AML接受移植。

核心结论

  • JAGN1缺陷患者表现为先天性中性粒细胞减少、早发性细菌感染、口疮和皮肤脓肿,可伴有骨骼代谢紊乱和综合征型表型。
  • 异基因造血干细胞移植是G-CSF治疗反应不佳或合并复杂感染患者的一种治疗选择。

研究设计与样本

  • 回顾性多中心研究,由ESID和EBMT IEWP开展,收集32例JAGN1缺陷患者数据。

主要发现

  • 患者共携带9种JAGN1纯合突变,所有患者均经历感染并发症。
  • 12例患者表现为身材矮小和面部特征,4例来自3个家族的患者出现神经发育迟缓。
  • 变异c.3G>A p.Met1见于9例患者,除1例身材矮小外从未与髓外症状相关。
  • 携带变异c.63G>T p.Glu21Asp和c130c>T p.His44Tyr的患者更常出现综合征型面部特征和骨代谢紊乱。
  • 6例患者因难治性中性粒细胞减少和严重感染接受异基因干细胞移植,1例因骨髓增生异常综合征和继发性急性髓系白血病接受移植。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Jagunal-homolog1 (JAGN1) is an endoplasmic reticulum-resident protein, which is part of the early secretory pathway and granulocyte colony-stimulating factor (CSF; G-CSF) receptor-mediated signaling. Autosomal recessively inherited variants in JAGN1 lead to congenital neutropenia, early-onset bacterial infections, aphthosis, and skin abscesses due to aberrant differentiation and maturation of neutrophils. Bone metabolism disorders and syndromic phenotype, including facial features, short stature, and neurodevelopmental delay, have been reported. Allogeneic hematopoietic stem cell transplantation (alloHSCT) is a treatment option for patients who respond poorly to therapy with G-CSF and those who suffer from complicated infections. In a retrospective multicenter study, data from 32 patients with JAGN1 deficiency were collected to describe the disease, perform phenotype-genotype analysis, and evaluate treatment modalities. Patients presented with 9 homozygous mutations in JAGN1. All patients experienced infectious complications. Twelve patients presented with short stature and facial features. Neurodevelopmental delay was observed in 4 patients from 3 families. Variant c.3G>A p.Met1, found in 9 patients, was never connected to extramedullary symptoms, except for short stature in 1 patient. Patients with the variants c.63G>T, p.Glu21Asp and c130c>T p.His44 Tyr presented more often with syndromic facial features and bone metabolism disorders. Six patients underwent allogeneic stem cell transplantation due to therapy-refractory neutropenia and severe infections, 1 received the graft because of myelodysplastic syndrome and secondary acute myeloid leukemia. Two patients had to undergo a second transplantation because of autologous reconstitution. One patient who did not undergo transplantation died at age 5 years due to pancolitis and septicemia. All 31 other patients were alive and healthy at the last follow-up.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Fekadu-Siebald J, Salzmann-Manrique E, Heusel JR, et al. Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients: a multicenter study by ESID and EBMT IEWP. Blood Adv. 2025. PMID: 39775668. doi:10.1182/bloodadvances.2024014344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。